Variability of insulin degludec and glargine 300 U/mL: A matter of methodology or just marketing?

Diabetes Obes Metab. 2018 Sep;20(9):2051-2056. doi: 10.1111/dom.13365. Epub 2018 Jun 10.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 1*
  • Humans
  • Hypoglycemic Agents
  • Insulin Glargine
  • Insulin, Long-Acting
  • Marketing

Substances

  • Hypoglycemic Agents
  • Insulin, Long-Acting
  • Insulin Glargine
  • insulin degludec